as 11-15-2024 4:00pm EST
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Founded: | 1904 | Country: | United States |
Employees: | N/A | City: | RADNOR |
Market Cap: | 16.8B | IPO Year: | 2019 |
Target Price: | $27.57 | AVG Volume (30 days): | 6.8M |
Analyst Decision: | Buy | Number of Analysts: | 15 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.45 | EPS Growth: | -16.59 |
52 Week Low/High: | $19.14 - $28.00 | Next Earning Date: | 10-25-2024 |
Revenue: | $6,819,800,000 | Revenue Growth: | -3.12% |
Revenue Growth (this year): | -0.13% | Revenue Growth (next year): | 1.58% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Eck Steven W | AVTR | SVP & Chief Accounting Officer | Sep 5 '24 | Sell | $25.06 | 3,525 | $88,336.50 | 29,544 |
AVTR Breaking Stock News: Dive into AVTR Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
MT Newswires
3 days ago
PR Newswire
3 days ago
Argus Research
5 days ago
Zacks
10 days ago
PR Newswire
11 days ago
Argus Research
12 days ago
Zacks
20 days ago
The information presented on this page, "AVTR Avantor Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.